A practical reference on synaptogenesis: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-03-24. Anything still debated is marked as such rather than presented as settled.
Dihexa is a synthetic peptide whose structure is modeled on angiotensin IV. Its chemical name often appears as N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, though vendor and publication naming can differ. The molecule combines a short amino acid sequence with a hexanoic acid group and an amide terminus. It is classed as a small research peptide rather than a conventional drug. Databases may list it under several synonyms, so matching names are important when comparing sources.
The angiotensin IV connection places dihexa in a family of short peptides studied for effects on central nervous system signaling. Angiotensin IV itself is a metabolite of angiotensin II, and analogs have been explored in cardiovascular and neurological research. Dihexa differs from the natural peptide through structural modifications intended to alter stability and receptor interactions. Published descriptions sometimes call it a hepatocyte growth factor mimetic, although that label reflects proposed activity rather than a confirmed clinical mechanism.
Most published reports on dihexa come from cell cultures and animal models. Studies have examined markers of synapse formation, dendritic spine density, and performance on learning tasks in rodents. Proposed mechanisms center on hepatocyte growth factor and its c-Met receptor, with additional attention to angiotensin IV-related pathways. These findings are experimental and have not been confirmed as clinical benefits in humans. The literature often uses different tasks and endpoints, which complicates direct comparison across studies.
Regulatory status differs by country, but dihexa is generally not approved as a therapeutic product. It is often sold as a research chemical, which means purity, labeling, and handling fall outside pharmaceutical drug standards. Some jurisdictions restrict the sale of peptides intended for human consumption. Researchers and suppliers may therefore face different legal requirements depending on location. Import rules and customs enforcement can also affect how such compounds move across borders.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic peptide analog | Modeled on angiotensin IV; not a natural hormone. |
| Common synonyms | Dihexa; N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide | Naming conventions differ across vendors and papers. |
| CAS Registry Number | 1401708-83-6 | Listed in some chemical databases; verify against primary sources. |
| Appearance | White to off-white powder | Typical form for lyophilized research peptides. |
| Solubility | Soluble in DMSO; limited in water | Organic stock solutions are common in laboratory settings. |
In laboratory settings, dihexa is typically handled as a lyophilized peptide powder. Appropriate personal protective equipment and a ventilated workspace are standard practices for weighing and transferring research chemicals. Because the compound lacks regulatory approval for clinical use, it should not be given to people. Institutional safety rules and local regulations govern its acquisition, storage, and disposal. Suppliers often provide a certificate of analysis that lists purity, identity, and batch-specific handling notes.
Dissolution depends on the peptide’s salt form, purity, and the chosen solvent. Dimethyl sulfoxide is commonly used to prepare concentrated stock solutions, while aqueous buffers may show limited solubility. Sonication or gentle warming can sometimes aid dissolution, but excessive heat may promote degradation. Once in solution, the material is generally kept cold and protected from light. Researchers should verify solubility for each lot rather than assuming uniform behavior across suppliers.
Dihexa is a synthetic peptide with the chemical name N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, and it is structurally related to angiotensin IV, a naturally occurring peptide fragment. Researchers developed it as a modified analog intended to alter stability and activity relative to the parent peptide. Its short sequence and fatty acid chain distinguish it from many endogenous peptides, and published studies often describe it under the abbreviation dihexa. The compound is classified as a laboratory compound rather than an approved therapeutic in most jurisdictions.
Early laboratory work focused on its effects on synaptic connectivity and neuronal signaling. In cell and animal models, dihexa has been reported to promote the formation of new synapses, a process called synaptogenesis. These findings have generated interest in cognitive research, but the evidence base remains mostly preclinical. Human clinical trials with clear safety and efficacy endpoints are limited or absent in the public literature. Whether these effects translate to humans is an open question.
=== Thioredoxin reductase === Thioredoxin reductase uses a cysteine-selenocysteine pair to reduce the disulfide in thioredoxin. The selenocysteine is arranged in an unusual Sec-His-Glu catalytic triad, which tunes its pKa.
Low-dose bicalutamide has been found to be effective in the treatment of hirsutism in women in clinical studies. In one of the studies, the medication was well tolerated, all of the patients experienced a visible increase in hair density, and a highly significant clinical improvement was observed with the Ferriman–Gallwey score decreasing by 41.2% at 3 months and by 61.6% at 6 months (from 22.0 ± 5.1 to 8.6 ± 3.5). According to a 2013 review, "Low dose bicalutamide (25 mg/day) was shown to be effective in the treatment of hirsutism related to IH and PCOS. It does not have any significant side effects [or lead] to irregular periods." In 2017, the combination of bicalutamide with a combined birth control pill was evaluated in a phase III clinical trial for the treatment of severe hirsutism in women with PCOS, and was found to be significantly more effective than a combined birth control pill alone. In addition, bicalutamide was shown to be safe and to produce no side effects, except for a significant increase in total cholesterol and low-density lipoprotein levels. Studies have reported bicalutamide to be effective in the treatment of scalp hair loss in women. In addition to hirsutism, bicalutamide can be used in the treatment of acne in women. Flutamide has generally been found to reduce symptoms of acne by 80 or 90% even at low doses, with several studies showing complete acne clearance. In one study, it decreased acne scores by 80% within 3 months, whereas the SAA spironolactone decreased symptoms by only 40% in the same time period.
The Germans also made use of CH for their own passive radar system, known as Klein Heidelberg. This used CH's transmissions as their source, and a series of antennas along the Channel coast as the receiver. By comparing the time of arrival of the signals from a selected aircraft, its range and direction could be determined with some accuracy. Since the system sent out no signals of its own, the allies were not aware of it until they overran the stations in 1944. Most of the stations had only just been built when they were overrun.
Sources: en.wikipedia.org
=== John-Daniel Stern === John-Daniel "JD" Stern (Adain Bradley) is Harper's estranged twin brother, who disappeared from her life when the two were teenagers. In series 2, Harper tracks down her brother to Berlin, where he works as a line cook. The two spend the night at a club, and the next morning, JD relapses on his meth addiction. The two have a vicious argument over their childhood growing up with an abusive mother; JD reveals he ran away in part due to Harper exacerbating the pressure their mother put on him to be a star tennis player, but Harper maintains that she too escaped a traumatic upbringing. Harper begs JD to come home with her, but rebuffs her, branding his sister a selfish narcissist who was complicit in the abuse he suffered. Harper is left deeply shaken by the encounter. In series 4, JD calls Harper to tell her that their mother died in a freak accident, having fallen down the stairs while collecting an Amazon delivery. Harper struggles to grieve her mother's death given her traumatic childhood, as well as her preoccupation with her work.
== Origin and history == S. affinis originates from central and northern China. It had been cultivated in China by the 13th century. Before S. affinis was introduced to Europe, a related crop named S. palustris was collected in nature to be consumed as a vegetable. Later on the Germanic peoples used S. recta, another relative of S. affinis, as a medicinal plant. The plant was then cultivated from the 18th century onwards. In 1882 the crop was cultivated on a farm for the first time in Crosne. S. affinis is the only labiate which is cultivated as vegetable in Europe. At the beginning of the 20th century S. affinis became more and more popular until it was abandoned again in the 1970s due to problems with viruses and the plant's strong vagility (tendency to spread). Since 1990 there has been a rise in the cultivation of S. affinis with availability in some markets and grocery stores. The plant is listed in the "Handbook of Alien Species in Europe" as an invasive plant in Europe.
== Total synthesis == Due to the high potency and clinical need for cancer treatments, epothilones have been the target of many total syntheses. The first group to publish the total synthesis of epothilones was S. J. Danishefsky et al. in 1996. This total synthesis of epothilone A was achieved via an intramolecular ester enolate-aldehyde condensation. Other syntheses of epothilones have been published by Nicolaou, Schinzer, Mulzer, and Carreira. In this approach, key building blocks aldehyde, glycidols, and ketoacid were constructed and coupled to the olefin metathesis precursor via an aldol reaction and then an esterification coupling. Grubbs' catalyst was employed to close the bis terminal olefin of the precursor compound. The resulting compounds were cis- and trans-macrocyclic isomers with distinct stereocenters. Epoxidation of cis- and trans-olefins yield epothilone A and its analogs. One of the total syntheses of epothilone B is outlined below and was described by the laboratory of K. C. Nicolaou. The retrosynthetic analysis revealed 1, 2, and 3 as the building blocks (Figure 1).
Sources: en.wikipedia.org
A stapled peptide is a modified peptide (class A peptidomimetic), typically in an alpha-helical conformation, that is constrained by a synthetic brace ("staple"). The staple is formed by a covalent linkage between two amino acid side-chains, forming a peptide macrocycle. Staples, generally speaking, refer to a covalent linkage of two previously independent entities, although the term was originally used to describe a non-covalent interaction between two hydrophobic amino acids in protein alpha-helices. Peptides with multiple, tandem staples are sometimes referred to as stitched peptides. Among other applications, peptide stapling is notably used to enhance the pharmacologic performance of peptides.
Religion and alcohol have a complex history. The world's religions have had different relationships with alcohol, reflecting diverse cultural, social, and religious practices across different traditions. While some religions strictly prohibit alcohol consumption, viewing it as sinful or harmful to spiritual and physical well-being, others incorporate it into their rituals and ceremonies. Throughout history, alcohol has held significant roles in religious observances, from the use of sacramental wine in Christian sacraments to the offering and moderate drinking of omiki (sacramental sake) in Shinto purification rituals.
== Deaths == 1 January – Sally Oppenheim-Barnes, Baroness Oppenheim-Barnes, 96, British politician, minister of state for consumer affairs (1979–1982), MP (1970–1987), and member of the House of Lords (1989–2019). 4 January – Jenny Randerson, Baroness Randerson, 76, Welsh politician and peer, acting Deputy First Minister of Wales (2001–2002) and member of the House of Lords (since 2011). 24 January – Joan Hanham, Baroness Hanham, 85, British politician, member of the House of Lords (1999–2020) and leader of the Kensington and Chelsea Council (1989–2000). 1 February – John Montagu, 11th Earl of Sandwich, 81, British aristocrat, businessman and politician, member of the House of Lords (1995–2024). 7 February – Dafydd Elis-Thomas, Baron Elis-Thomas, 78, Welsh politician, llywydd of the Senedd (1999–2011), MP (1974–1992) and member of the House of Lords (since 1992). 16 February – Barry Panter, politician (Mayor of Newcastle-under-Lyme), car crash. (death reported on this date) 19 February – Joe Haines, 97, British journalist and public servant, Downing Street press secretary (1969–1970, 1974–1976). 27 March – Christina McKelvie, 57, Scottish politician, MSP (since 2007), minister for culture (2023–2024) and drugs and alcohol policy (since 2024), breast cancer. 30 March – Stanley Kalms, Baron Kalms, 93, British businessman, chairman of Currys, and life peer, member of the House of Lords (2004–2024). 31 March – Janric Craig, 3rd Viscount Craigavon, 80, British hereditary peer and member of the House of Lords (since 1974) 23 April – Peter Taaffe, 83, British Marxist militant.
Sources: en.wikipedia.org
Dihexa is a synthetic peptide analog related to angiotensin IV. It is studied in preclinical research for effects on neural signaling and synapse formation. It is not an approved medicine.
No. Dihexa shares a conceptual link to angiotensin IV but has different structural features. Those changes are intended to modify its behavior in biological systems.
It often appears as N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide. Synonyms and CAS listings vary, so cross-checking identifiers is necessary.
Published human clinical trial data are limited or absent. Most available evidence comes from laboratory and animal studies. Human safety and efficacy remain unresolved.